Invivyd (IVVD) EPS (Diluted) Growth (1y) (2022 - 2025)
Invivyd (IVVD) EPS (Diluted) Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,192.35 Bn | 67,192.06 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.52 Bn | 466.73 Bn | 1.35 Bn | 17,091.12% |
| 5 | Vertex Pharmaceuticals | 121.73 Bn | 114.48 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 69.88 Bn | 61.13 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 63.11 Bn | 63.11 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.70 Bn | 1.41 Bn | 96.09% |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Invivyd | 105.05 Mn | -121.64 Mn | 16.07 Mn | 54.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54.51% |
| Sep 30, 2025 | 86.74% |
| Jun 30, 2025 | 69.13% |
| Mar 31, 2025 | 79.19% |
| Dec 31, 2024 | 77.56% |
| Sep 30, 2024 | -27.96% |
| Jun 30, 2024 | 16.11% |
| Mar 31, 2024 | -87.64% |
| Dec 31, 2023 | -55.71% |
| Sep 30, 2023 | 16.78% |
| Jun 30, 2023 | 8.60% |
| Mar 31, 2023 | 64.57% |
| Dec 31, 2022 | 77.12% |
| Sep 30, 2022 | 49.94% |
| Jun 30, 2022 | 99.70% |